Reduced cortical innervation of the subthalamic nucleus in MPTP-treated parkinsonian monkeys

Brain

Volumn 138, Issue 4, 2015, Pages 946-962

  Mathai, Abraham ^a   Ma, Yuxian ^a   Paré, Jean Francois ^a   Villalba, Rosa M ^a   Wichmann, Thomas ^a,b   Smith, Yoland ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cortico subthalamic; hyperdirect; Parkinson's disease; synaptic plasticity; vesicular glutamate transporter

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

ADULT; ANATOMICAL CONCEPTS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HAPLORHINI; IN VIVO STUDY; MALE; MICROSCOPY; MPTP-INDUCED PARKINSONISM; NERVE ENDING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; SYNAPSE; ANIMAL; BASAL GANGLION; CHEMICALLY INDUCED; CORPUS STRIATUM; DRUG EFFECTS; GLOBUS PALLIDUS; PARKINSON DISEASE; PATHOLOGY; RHESUS MONKEY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BASAL GANGLIA; CEREBRAL CORTEX; CORPUS STRIATUM; FEMALE; GLOBUS PALLIDUS; HAPLORHINI; MACACA MULATTA; MALE; PARKINSON DISEASE, SECONDARY; SUBTHALAMIC NUCLEUS;

EID: 84929104403     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv018     Document Type: Article

References (95)

1. Baudrexel S, Witte T, Seifried C, von Wegner F, Beissner F, Klein JC, et al. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease. Neuroimage 2011; 55: 1728-38.
2. Baufreton J, Atherton JF, Surmeier DJ, Bevan MD. Enhancement of excitatory synaptic integration by GABAergic inhibition in the sub-thalamic nucleus. J Neurosci 2005; 25: 8505-17.
3. Baufreton J, Bevan MD. D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus. J Physiol 2008; 586: 2121-42.
4. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994; 72: 507-20.
5. Bevan MD, Francis CM, Bolam JP. The glutamate-enriched cortical and thalamic input to neurons in the subthalamic nucleus of the rat: convergence with GABA-positive terminals. J Comp Neurol 1995; 361: 491-511.
6. Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pal-lidus network. Trends Neurosci 2002; 25: 525-531.
7. Bevan MD, Atherton JF, Baufreton J. Cellular principles underlying normal and pathological activity in the subthalamic nucleus. Curr Opin Neurobiol 2006; 16: 621-28.
8. Bogenpohl J, Galvan A, Hu X, Wichmann T, Smith Y. Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex. Neuropharmacology 2013; 66: 242-52.
9. Calabresi P, Mercuri NB, Sancesario G, Bernardi G. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain 1993; 116 (Pt 2): 433-52.
10. Calabresi P, Picconi B, Tozzi A, Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 2007; 30: 211-19.
11. Campbell GA, Eckardt MJ, Weight FF. Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res 1985; 333: 261-70.
12. Cragg SJ, Baufreton J, Xue Y, Bolam JP, Bevan MD. Synaptic release of dopamine in the subthalamic nucleus. Eur J Neurosci 2004; 20: 1788-802.
13. Devergnas A, Pittard D, Bliwise D, Wichmann T. Relationships between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys. Neurobiol Dis 2014; 68: 156-66.
14. Fan KY, Baufreton J, Surmeier DJ, Chan CS, Bevan MD. Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. J Neurosci 2012; 32: 13718-28.
15. Fernandez HH, Rodriquez RL, Skidmore FM, Okun MS. Key concepts for surgical therapy for Parkinson's disease and movement disorders. A Practical Approach to Movement Disorders. 1 edn. New York: Demos Medical Publishing; 2007.
16. Fremeau RT Jr, Voglmaier S, Seal RP, Edwards RH. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 2004; 27: 98-103.
17. Fremeau RT Jr, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, et al. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 2001; 31: 247-60.
18. Fujiyama F, Unzai T, Nakamura K, Nomura S, Kaneko T. Difference in organization of corticostriatal and thalamostriatal synapses between patch and matrix compartments of rat neostriatum. Eur J Neurosci 2006; 24: 2813-24.
19. Fujiyama F, Kuramoto E, Okamoto K, Hioki H, Furuta T, Zhou L, et al. Presynaptic localization of an AMPA-type glutamate receptor in corticostriatal and thalamostriatal axon terminals. Eur J Neurosci 2004; 20: 3322-30.
20. Galvan A, Hu X, Smith Y, Wichmann T. Localization and function of GABA transporters in the globus pallidus of parkinsonian monkeys. Exp Neurol 2010; 223: 505-15.
21. Galvan A, Hu X, Smith Y, Wichmann T. Localization and pharmacological modulation of GABA-B receptors in the globus pallidus of parkinsonian monkeys. Exp Neurol 2011; 229: 429-39.
22. Garber JC, Barbee RW, Bielitzki JT, Clayton LA, Donovan JC, Hendriksen CFM, et al. Guide for the Care and Use of Laboratory Animals. 8 edn. Washington, DC: The National Academies Press; 2010.
23. Gonzales KK, Pare JF, Wichmann T, Smith Y. GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen. J Comp Neurol 2013; 521: 2502-22.
24. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009; 324: 354-59.
25. Gundersen HJ, Osterby R. Optimizing sampling efficiency of stereo-logical studies in biology: or 'do more less well. J Microsc 1981; 121: 65-73.
26. Hadipour-Niktarash A, Rommelfanger KS, Masilamoni GJ, Smith Y, Wichmann T. Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys. J Neurophysiol 2012; 107: 1500-12.
27. Hassani OK, Feger J. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydro-xydopamine-lesioned rats: an electrophysiological and c-Fos study. Neurosci 1999; 92: 533-43.
28. Haynes WI, Haber SN. The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for Basal Ganglia models and deep brain stimulation. J Neurosci 2013; 33: 4804-814.
29. Helmich RC, Aarts E, de Lange FP, Bloem BR, Toni I. Increased dependence of action selection on recent motor history in Parkinson's disease. J Neurosci 2009; 29: 6105-113.
30. Hur EE, Zaborszky L. Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization study [corrected]. J Comp Neurol 2005; 483: 351-73.
31. Ingham CA, Hood SH, Arbuthnott GW. Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 1989; 503: 334-38.
32. Jahfari S, Waldorp L, van den Wildenberg WP, Scholte HS, Ridderinkhof KR, Forstmann BU. Effective connectivity reveals important roles for both the hyperdirect (fronto-subthalamic) and the indirect (fronto-striatal-pallidal) fronto-basal ganglia pathways during response inhibition. J Neurosci 2011; 31: 6891-99.
33. Kaneko T, Fujiyama F. Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci Res 2002; 42: 243-50.
34. Kashani A, Betancur C, Giros B, Hirsch E, El Mestikawy S. Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging 2007; 28: 568-78.
35. Kita H, Chang HT, Kitai ST. The morphology of intracellularly labeled rat subthalamic neurons: a light microscopic analysis. J Comp Neurol 1983; 215: 245-57.
36. Kita T, Kita H. The subthalamic nucleus is one of multiple innervation sites for long-range corticofugal axons: a single-axon tracing study in the rat. J Neurosci 2012; 32: 5990-9.
37. Kliem MA, Pare JF, Khan ZU, Wichmann T, Smith Y. Ultrastructural localization and function of dopamine D1-like receptors in the sub-stantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys. Eur J Neurosci 2010; 31: 836-51.
38. Kubota Y, Hatada S, Kondo S, Karube F, Kawaguchi Y. Neocortical inhibitory terminals innervate dendritic spines targeted by thalamo-cortical afferents. J Neurosci 2007; 27: 1139-50.
39. Lavoie B, Parent A. Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J Comp Neurol 1994; 344: 210-31.
40. Li S, Arbuthnott GW, Jutras MJ, Goldberg JA, Jaeger D. Resonant antidromic cortical circuit activation as a consequence of high-frequency subthalamic deep-brain stimulation. J Neurophysiol 2007; 98: 3525-37.
41. Liguz-Lecznar M, Skangiel-Kramska J. Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system. Acta Neurobiol Exp (Wars) 2007; 67: 207-18.
42. Lindefors N, Ungerstedt U. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci Lett 1990; 115: 248-52.
43. MacDonald V, Halliday GM. SElective loss of pyramidal neurons in the pre-supplementary motior cortex in Parkinson's disease. Mov. Disorders 2002; 17: 1166-73.
44. Mallet N, Pogosyan A, Sharott A, Csicsvari J, Bolam JP, Brown P, et al. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J Neurosci 2008; 28: 4795-806.
45. Masilamoni GJ, Bogenpohl JW, Alagille D, Delevich K, Tamagnan G, Votaw JR, et al. Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain 2011; 134: 2057-2073.
46. Mathai A, Smith Y. The corticostriatal and corticosubthalamic pathways: two entries, one target. So what? Front Syst Neurosci 2011; 5: 64.
47. Mathai A, Pare JF, Jenkins S, Smith Y. Glutamatergic inputs to the subthalamic nucleus: a quantitative analysis of the synaptic micro-circuitry of vGluT1-and vGluT2-containing terminals in normal and Parkinsonian nonhuman primates. In: Xth Triennial Meeting of the International Basal Ganglia Society. Long Branch, NJ 2010.
48. Mathai A, Ma Y, Wichmann T, Smith Y. Glutamatergic inputs to the subthalamic nucleus degenerate in experimental parkinsonism. 41st Annual Meeting of the Society for Neuroscience. Washington, DC, 2011abstract.
49. McMillan J, Galvan A, Wichmann T, Bloomsmith M. The use of positive reinforcement during pole and collar training of rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci 2010; 49: 705-6.
50. Meshul CK, Cogen JP, Cheng HW, Moore C, Krentz L, McNeill TH. Alterations in rat striatal glutamate synapses following a lesion of the cortico-and/or nigrostriatal pathway. Exp Neurol 2000; 165: 191-206.
51. Mink JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 1993; 3: 950-7.
52. Mitrano DA, Pare JF, Smith Y. Ultrastructural relationships between cortical, thalamic, and amygdala glutamatergic inputs and group I metebotropic glutamate receptors in the rat accumbens. J Comp Neurol 2010; 518: 1315-29.
53. Monakow KH, Akert K, Kunzle H. Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Exp Brain Res 1978; 33: 395-403.
54. Moran A, Bergman H, Israel Z, Bar-Gad I. Subthalamic nucleus organization revealed by parkinsonian neuronal oscillations and synchrony. Brain 2008; 131: 3395-409.
55. Moshel S, Shamir RR, Raz A, de Noriega FR, Eitan R, Bergman H, et al. Subthalamic nucleus long-range synchronization-an independent hallmark of human Parkinson's disease. Front Syst Neurosci 2013; 7: 79.
56. Nambu A, Tokuno H, Takada M. Functional significance of the cor-tico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci Res 2002; 43: 111-17.
57. Nambu A, Takada M, Inase M, Tokuno H. Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci 1996; 16: 2671-83.
58. Nambu A, Tokuno H, Hamada I, Kita H, Imanishi M, Akazawa T, et al. Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol 2000; 84: 289-300.
59. Ni Z, Gao D, Bouali-Benazzouz R, Benabid AL, Benazzouz A. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. Eur J Neurosci 2001; 14: 373-81.
60. Onn SP, West AR, Grace AA. Dopamine-mediated regulation of stri-atal neuronal and network interactions. Trends Neurosci 2000; 23: S48-56.
61. Orieux G, Francois C, Feger J, Hirsch EC. Consequences of dopamin-ergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. J Neurosci 2002; 22: 8762-70.
62. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995; 20: 91-127.
63. Parent M, Parent A. Single-axon tracing study of corticostriatal projections arising from primate motor cortex in primates. J Comp Neurol 2006; 496: 202-13.
64. Paxinos G, Huang X-F, Toga AW. The Rhesus Monkey Brain in Stereotaxic Coordinates. 1st edn. San Diego, CA: Academic Press; 1999.
65. Peters A, Palay SL, Webster HD. The Fine Structure of the Nervous System: Neurons and their Supporting Cells. 3rd edn. New York: Oxford University Press; 1991.
66. Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y. Differential synap-tology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 2006; 499: 231-43.
67. Raju DV, Ahern TH, Shah DJ, Wright TM, Standaert DG, Hall RA, et al. Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of par-kinsonism. Eur J Neurosci 2008; 27: 1647-58.
68. Ranck JB Jr. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res 1975; 98: 417-40.
69. Rommelfanger KS, Wichmann T. Extrastriatal dopaminergic circuits of the Basal Ganglia. Front Neuroanat 2010; 4: 139.
70. Sadikot AF, Parent A, Francois C. Efferent connections of the centro-median and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections. J Comp Neurol 1992; 315: 137-59.
71. Schmitz C, Hof PR. Design-based stereology in neuroscience. Neuroscience 2005; 130: 813-31.
72. Schmidt R, Leventhal DK, Mallet N, Chen F, Berke JD. Canceling actions involves a race between basal ganglia pathways. Nat Neurosci 2013; 16: 1118-24.
73. Shen KZ, Johnson SW. Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol 2000; 525 (Pt 2): 331-41.
74. Shimamoto SA, Ryapolova-Webb ES, Ostrem JL, Galifianakis NB, Miller KJ, Starr PA. Subthalamic nucleus neurons are synchronized to primary motor cortex local field potentials in Parkinson's disease. J Neurosci 2013; 33: 7220-33.
75. Shink E, Bevan MD, Bolam JP, Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neurosci 1996; 73: 335-357.
76. Smith Y, Hazrati LN, Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol 1990; 294: 306-23.
77. Smith Y, Wichmann T, Delong MR. Corticostriatal and mesocortical dopamine systems: do species differences matter? Nat Rev Neurosci 2013; 15: 63.
78. Udupa K, Fox SH. Subthalamic nucleus and striatum: the red and green signals to regulate the traffic of basal ganglia circuitry. Mov Disorders 2013; 28: 1802.
79. Unal G, Pare JF, Smith Y, Pare D. Cortical inputs innervate calbindin-immunoreactive interneurons in the rat basolateral amygdaloid complex. J Comp Neurol 2014; 522: 1915-28.
80. Villalba R, Wichmann T, Smith Y. Preferential loss of thalamostriatal over corticostriatal glutamatergic synapses in parkinsonian monkeys In: 43rd Annual Meeting of the Society for Neuroscience. San Diego, CA; 2013a; abstr.
81. Villalba RM, Smith Y. Differential structural plasticity of corticostria-tal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J Comp Neurol 2011; 519: 989-1005.
82. Villalba RM, Smith Y. Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? Neurosci 2013; 251: 2-20.
83. Villalba RM, Lee H, Smith Y. Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys. Exp Neurol 2009; 215: 220-27.
84. Villalba RM, Wichmann T, Smith Y. Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease. Brain Struct Funct 2013b; 219: 381-94.
85. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482-97.
86. West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 1999; 22: 51-61.
87. Wichmann T, DeLong MR. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder. Ann N Y Acad Sci 2003; 991: 199-213.
88. Wichmann T, Dostrovsky JO. Pathological basal ganglia activity in movement disorders. Neuroscience 2011; 198: 232-44.
89. Wichmann T, Kliem MA, DeLong MR. Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates. Exp Neurol 2001; 167: 410-24.
90. Wichmann T, Delong MR, Guridi J, Obeso JA. Milestones in research on the pathophysiology of Parkinson's disease. Mov Disord 2011; 26: 1032-41.
91. Williams D, Tijssen M, Van Bruggen G, Bosch A, Insola A, Di Lazzaro V, et al. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 2002; 125: 1558-69.
92. Williams D, Kuhn A, Kupsch A, Tijssen M, Van Bruggen G, Speelman H, et al. Behavioural cues are associated with modulations of synchronous oscillations in human subthalamic nucleus. Brain 2003; 126: 1975-85.
93. Williams D, Kuhn A, Kupsch A, Tijssen M, Van Bruggen G, Speelman H, et al. The relationship between oscillatory activity and motor reaction time in the parkinsonian subthalamic nucleus. Eur J Neurosci 2005; 21: 249-58.
94. Wylie SA, Ridderinkhof KR, Bashore TR, van den Wildenberg WP. The effect of Parkinson's disease on the dynamics of on-line and proactive cognitive control during action selection. J Cogn Neurosci 2010; 22: 2058-73.
95. Zhu ZT, Shen KZ, Johnson SW. Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro. Neuropharmacol 2002; 42: 772-81.